Home
› NDC Lookup
› 47682-0811-13
Medi First Pain Relief ACETAMINOPHEN, ASPIRIN, SALICYLAMIDE and CAFFEINE 110; 162; 32.4; 152 mg; mg; mg; mg Tablet, 500-count — NDC 47682-811-13 (Billing 47682-0811-13)
by Unifirst First Aid Corporation · 250 PACKET in 1 BOX (47682-811-13) / 2 TABLET in 1 PACKET (47682-811-99)
NDC 47682-811-13 (billing 47682-0811-13) is a package of 500 tablets of Medi First Pain Relief ACETAMINOPHEN, ASPIRIN, SALICYLAMIDE and CAFFEINE 110; 162; 32.4; 152 mg; mg; mg; mg Tablet from Unifirst First Aid Corporation, no longer marketed, no longer in the FDA NDC Directory.
NDC 47682-0811-13
🏷️ FDA NDC (as labeled)
47682-811-13
billing pads the product segment with a zero
This package
Contains500-count
Pack sizes4 compare ↓
🗂️ Data synced Mar 13, 2024 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Excluded from the active FDA NDC Directory.
The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Mar 2024. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory.
Search the FDA NDC Directory ↗
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
47682-811-13
Product NDC
47682-811
11-digit billing NDC
47682081113
NCPDP billing unit
EA — each (per item)
Application #
part343
Established class (EPC)
Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing status
Discontinued
FDA listing status
Discontinued by firm (certified through Mar 2024)
Route
ORAL
Dosage form
TABLET
Substance
ACETAMINOPHEN; ASPIRIN; CAFFEINE; SALICYLAMIDE
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GCN Seq No
057728
GCN
22939
HICL code
001796
Ingredient (HICL)
Asa/Salicylam/Acetaminoph/Caff
HIC1 code
H
Therapeutic class — broad (HIC1)
Nervous System (Except Autonomic)
HIC2 code
H3
Therapeutic class — intermediate (HIC2)
Analgesics
HIC3 code
H3D
Therapeutic class — specific (HIC3)
Analgesic/Antipyretics, Salicylates
AHFS code
20:12.18.00
AHFS class
Platelet-Aggregation Inhibitors
FDB label name
PAIN RELIEF TABLET
FDB brand name
Pain Relief
Legend status
O — Over-the-counter (OTC) drug or device
Quick answers for NDC 47682-811-13
- GSN (GCN sequence number): 057728
- GCN: 22939
- HICL (First Databank): 001796
- AHFS class code: 20:12.18.00
- 11-digit billing NDC: 47682081113
Why two NDCs?
The FDA registers this code as 47682-811-13 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 47682-0811-13. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
Clinical
Label name PAIN RELIEF TABLET Ingredient Asa/Salicylam/Acetaminoph/Caff
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about ACETAMINOPHEN, ASPIRIN, SALICYLAMIDE and CAFFEINE?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 47682-0811-13 47682-811-13 You're viewing this | 250 PACKET in 1 BOX (47682-811-13) / 2 TABLET in 1 PACKET (47682-811-99) | 2008-12-30 | Discontinued by firm |
| 47682-0811-33 47682-811-33 | 50 PACKET in 1 BOX (47682-811-33) / 2 TABLET in 1 PACKET | 2008-12-30 | Discontinued by firm |
| 47682-0811-48 47682-811-48 | 125 PACKET in 1 BOX (47682-811-48) / 2 TABLET in 1 PACKET | 2008-12-30 | Discontinued by firm |
| 47682-0811-99 47682-811-99 | 2 TABLET in 1 PACKET (47682-811-99) | 2008-12-30 | Discontinued by firm |
Pack size FAQ
What quantity is in NDC 47682-0811-13?
NDC 47682-0811-13 is a 500-count package — 250 packet in 1 box / 2 tablet in 1 packet.
What is the difference between NDC 47682-0811-13 and NDC 47682-0811-99?
Both are Medi First Pain Relief ACETAMINOPHEN, ASPIRIN, SALICYLAMIDE and CAFFEINE 110; 162; 32.4; 152 mg; mg; mg; mg Tablet — the drug itself is identical. NDC 47682-0811-13 is the 500-count package, while NDC 47682-0811-99 is the 2 tablets package.
What NDC number is used to bill for this package of Medi First Pain Relief ACETAMINOPHEN, ASPIRIN, SALICYLAMIDE and CAFFEINE 110; 162; 32.4; 152 mg; mg; mg; mg Tablet?
Bill NDC 47682-0811-13 — the 11-digit billing format is 47682081113. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Medi First Pain Relief 110; 162; 32.4; 152 mg/1; mg/1; mg/1; mgthis 47682-0811-13 | Unifirst | 500 tablets | — | — | Discontinued | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
Availability & generic status
📍
2026
Currently FDA-listed
listed with the FDA
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerUnifirst First Aid Corporation
FDA applicationpart343 (OTC MONOGRAPH NOT FINAL)
Labeler code47682
Product typeHuman Otc Drug
Portfolio183 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
About this NDC listing & data coverage
Over-the-counter (OTC) product
No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA. |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Not Final". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Why is there no full label on this page?
No structured FDA label (SPL) is currently linked to this NDC in DailyMed/openFDA. That can happen with older listings, certain OTC and repackaged products, and recently updated listings whose label has not yet propagated. The listing itself is still valid — this page shows everything the public feeds provide for this package.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 47682-811-13, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 47682-0811-13, written without dashes as 47682081113. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 47682-0811-13, the first segment (47682) is the labeler code FDA assigned to Unifirst First Aid Corporation; the middle segment (0811) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (13) identifies this exact package size and type. Together they name one specific package of one specific product.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 2 tablets (47682-0811-99), 100 tablets (47682-0811-33), 250 tablets (47682-0811-48). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Unifirst First Aid Corporation is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.